Sintx Technologies: Director Departs, CSO Appointed

Ticker: SINT · Form: 8-K · Filed: Mar 13, 2025 · CIK: 1269026

Sintx Technologies, Inc. 8-K Filing Summary
FieldDetail
CompanySintx Technologies, Inc. (SINT)
Form Type8-K
Filed DateMar 13, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: management-change, personnel

TL;DR

Sintx's Dr. Johnson is out as a director but in as CSO, effective immediately.

AI Summary

Sintx Technologies, Inc. announced on March 7, 2025, the departure of Director Dr. Robert L. Johnson and the appointment of Dr. Robert L. Johnson as Chief Scientific Officer. The company also elected Dr. Robert L. Johnson to its Board of Directors. These changes are effective immediately.

Why It Matters

This filing indicates a significant shift in leadership and scientific direction for Sintx Technologies, with a key individual transitioning from the board to a critical executive role.

Risk Assessment

Risk Level: medium — Changes in key personnel, especially a transition from a director to an executive role, can signal strategic shifts or internal dynamics that may impact the company's future performance.

Key Players & Entities

  • Sintx Technologies, Inc. (company) — Registrant
  • Dr. Robert L. Johnson (person) — Director and Chief Scientific Officer
  • March 7, 2025 (date) — Date of earliest event reported

FAQ

What is the effective date of Dr. Robert L. Johnson's departure as Director and appointment as Chief Scientific Officer?

The filing states that the earliest event reported is March 7, 2025, implying these changes are effective as of that date.

What was Dr. Robert L. Johnson's previous role at Sintx Technologies?

Dr. Robert L. Johnson was previously a Director of Sintx Technologies, Inc.

What is the new role Dr. Robert L. Johnson has taken on?

Dr. Robert L. Johnson has been appointed as the Chief Scientific Officer of Sintx Technologies, Inc.

Has Dr. Robert L. Johnson also been elected to the Board of Directors in his new capacity?

Yes, the filing indicates that Dr. Robert L. Johnson was elected to the Board of Directors.

What is the primary business of Sintx Technologies, Inc. according to the filing?

Sintx Technologies, Inc. is in the business of SURGICAL & MEDICAL INSTRUMENTS & APPARATUS, with Standard Industrial Classification code 3841.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 13, 2025 by Dr. Robert L. Johnson regarding Sintx Technologies, Inc. (SINT).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.